Laetrile and the FDA: a case of reverse regulation.
D000678:Amygdalin / Q000266:history / Q000627:therapeutic use*; D004341:Drug Evaluation; D004335:Drug and Narcotic Control / Q000331:legislation & jurisprudence; D035082:Federal Government; D033161:Government Regulation; D049673:History, 20th Century; D006801:Humans; D007880:Legislation, Drug; D009369:Neoplasms / Q000188:drug therapy; D026684:Personal Autonomy; D018570:Risk Assessment; D014481:United States; D014486:United States Food and Drug Administration
D000678:Amygdalin